Astera Labs (NASDAQ:ALAB) Director Stefan Dyckerhoff Sells 8,994 Shares

Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $4,047,300.00. Following the sale, the director owned 4,631 shares of the company’s stock, valued at approximately $2,083,950. The trade was a 66.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Stock Down 5.7%

NASDAQ ALAB traded down $24.44 during trading on Thursday, hitting $406.42. The company’s stock had a trading volume of 7,173,307 shares, compared to its average volume of 6,270,830. The firm has a 50 day moving average price of $306.18 and a 200 day moving average price of $202.33. The firm has a market cap of $69.66 billion, a P/E ratio of 319.16, a price-to-earnings-growth ratio of 4.94 and a beta of 3.66. Astera Labs, Inc. has a 52 week low of $88.18 and a 52 week high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Astera Labs by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after buying an additional 84,365 shares in the last quarter. Atreides Management LP lifted its holdings in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after acquiring an additional 1,754,593 shares during the period. State Street Corp boosted its stake in shares of Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after purchasing an additional 104,935 shares during the last quarter. Finally, Fred Alger Management LLC increased its position in shares of Astera Labs by 25.5% during the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after purchasing an additional 393,250 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. Evercore restated an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Royal Bank Of Canada lifted their target price on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Needham & Company LLC upped their price target on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Loop Capital initiated coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective for the company. Finally, Susquehanna lifted their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $265.75.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.